UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extrapolating Survival Data Using Historical Trial–Based a Priori Distributions

Value in health, 2019-09, Vol.22 (9), p.1012-1017

2019

Volltextzugriff (PDF)

Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis

British journal of haematology, 2020-06, Vol.189 (5), p.860-868

2020

Volltextzugriff (PDF)

Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligible patients with newly diagnosed multiple myeloma, using propensity score matching

EJHaem, 2021-02, Vol.2 (1), p.66-80

2021

Volltextzugriff (PDF)

Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible

EJHaem, 2020-11, Vol.1 (2), p.481-488

2020

Volltextzugriff (PDF)

Building stellar bulges and halo cores from massive clumps observed in the DYNAMO-HST sample

Monthly notices of the Royal Astronomical Society, 2024-03, Vol.529 (3), p.2702-2715

2024

Volltextzugriff (PDF)

A systematic literature review of disease progression in RPGR‐associated X‐linked retinitis pigmentosa

Acta ophthalmologica (Oxford, England), 2022-12, Vol.100 (S275), p.n/a

2022

Volltextzugriff (PDF)

Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma

The oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.e263-e269

2023

Volltextzugriff (PDF)

1225 Gastric Adenocarcinoma Incidence and Incidence-Based Mortality: A Population-Based Study of 62,863 Cases From the Surveillance, Epidemiology and End Results (SEER) Program Over Last Four Decades

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S684-S684

2019

Volltextzugriff (PDF)

FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S90-S90

2022

Volltextzugriff (PDF)

S0548 Assessment of the Quality of Upper Endoscopy Procedures Performed for Gastric Ulcers in a Tertiary Care Facility

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S259-S259

2020

Volltextzugriff (PDF)

S0558 Impact of Obesity on Healing of Gastric Ulcers, a Retrospective Single Center Study

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S259-S259

2020

Volltextzugriff (PDF)

Halo heating from fluctuating gas in a model dwarf

Monthly notices of the Royal Astronomical Society, 2023-03, Vol.521 (1), p.772-789

2023

Volltextzugriff (PDF)

Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

Value in health, 2018-01, Vol.21 (1), p.9-17

2018

Volltextzugriff (PDF)

1487 Vedolizumab-Induced Remission of Refractory Microscopic Colitis: A Single Institution Case Series

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S823-S823

2019

Volltextzugriff (PDF)

Hepatitis B virus core‐related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature

Reviews in medical virology, 2022-11, Vol.32 (6), p.e2353-n/a

2022

Volltextzugriff (PDF)

P091 XIAP MUTATION IS ASSOCIATED WITH TREATMENT RESISTANT CROHN’S DISEASE: A SINGLE INSTITUTION CASE SERIES

Inflammatory bowel diseases, 2020-01, Vol.26 (Supplement_1), p.S76-S77

2020

Volltextzugriff (PDF)

P111 CORRELATION OF FECAL CALPROTECTIN AND MUCOSAL BIOPSY IN IDENTIFYING SUBCLINICAL INFLAMMATION IN ULCERATIVE COLITIS PATIENTS: A PRELIMINARY STUDY

Inflammatory bowel diseases, 2020-01, Vol.26 (Supplement_1), p.S16-S17

2020

Volltextzugriff (PDF)

P032 NONINVASIVE BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE MONITORING: DRAWBACKS AND POTENTIAL

Inflammatory bowel diseases, 2019-02, Vol.25 (Supplement_1), p.S16-S16

2019

Volltextzugriff (PDF)

A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices

Value in health, 2024-09, Vol.27 (9), p.1179-1190

2024

Volltextzugriff (PDF)

Donor blood cultures and outcomes after lung transplantation: a single-center report

Transplant infectious disease, 2024-04, Vol.26 (2), p.e14224-e14224

2024

Volltextzugriff (PDF)

P085 DOSE ESCALATION (Q4) OF USTEKINUMAB SHOULD BE CONSIDERED FOR CROHN’S DISEASE PATIENTS WHO FAIL STANDARD DOSING

Inflammatory bowel diseases, 2020-01, Vol.26 (Supplement_1), p.S72-S73

2020

Volltextzugriff (PDF)

Reservoir Quality, Lithotype Assessment, and Geochemical Source Rock Analysis: Insights from Well Logs and Pyrolysis Data, Karama Field, North-Western Desert, Egypt

Geofluids, 2024, Vol.2024, p.1-22

2024

Volltextzugriff (PDF)

Clinical aspects of circulating miRNA‐335 in breast cancer patients: A prospective study

Journal of cellular biochemistry, 2019-06, Vol.120 (6), p.8975-8982

2019

Volltextzugriff (PDF)

Diagnostic value of PET imaging in clinically unresponsive patients

British journal of radiology, 2024-02, Vol.97 (1154), p.283-291

2024

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(13)
Humans
(7)
Multiple Myeloma
(5)
Bortezomib
(4)
Clinical Trials
(4)
Patients
(4)
Physical Sciences
(4)
Survival
(4)
Biomarkers
(3)
Dexamethasone
(3)
Hematology
(3)
Multiple Myeloma - Drug Therapy
(3)
Oncology
(3)
Risk Factors
(3)
Adult
(2)
Aged
(2)
Aged, 80 And Over
(2)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extrapolating Survival Data Using Historical Trial–Based a Priori Distributions

Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis

International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients

Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D‐VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant‐eligible patients with newly diagnosed multiple myeloma, using propensity score matching

Matching‐adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligible

Building stellar bulges and halo cores from massive clumps observed in the DYNAMO-HST sample

A systematic literature review of disease progression in RPGR‐associated X‐linked retinitis pigmentosa

Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma

1225 Gastric Adenocarcinoma Incidence and Incidence-Based Mortality: A Population-Based Study of 62,863 Cases From the Surveillance, Epidemiology and End Results (SEER) Program Over Last Four Decades

FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS

S0548 Assessment of the Quality of Upper Endoscopy Procedures Performed for Gastric Ulcers in a Tertiary Care Facility

S0558 Impact of Obesity on Healing of Gastric Ulcers, a Retrospective Single Center Study

Halo heating from fluctuating gas in a model dwarf

Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

1487 Vedolizumab-Induced Remission of Refractory Microscopic Colitis: A Single Institution Case Series

Hepatitis B virus core‐related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature

P091 XIAP MUTATION IS ASSOCIATED WITH TREATMENT RESISTANT CROHN’S DISEASE: A SINGLE INSTITUTION CASE SERIES

P111 CORRELATION OF FECAL CALPROTECTIN AND MUCOSAL BIOPSY IN IDENTIFYING SUBCLINICAL INFLAMMATION IN ULCERATIVE COLITIS PATIENTS: A PRELIMINARY STUDY

P032 NONINVASIVE BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE MONITORING: DRAWBACKS AND POTENTIAL

A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices

Donor blood cultures and outcomes after lung transplantation: a single-center report

P085 DOSE ESCALATION (Q4) OF USTEKINUMAB SHOULD BE CONSIDERED FOR CROHN’S DISEASE PATIENTS WHO FAIL STANDARD DOSING

Reservoir Quality, Lithotype Assessment, and Geochemical Source Rock Analysis: Insights from Well Logs and Pyrolysis Data, Karama Field, North-Western Desert, Egypt

Clinical aspects of circulating miRNA‐335 in breast cancer patients: A prospective study

Diagnostic value of PET imaging in clinically unresponsive patients

Aktive Filter

Suchergebnisse filtern